-
1
-
-
53049086856
-
Current and future standards in treatment of myasthenia gravis
-
Gold R, Schneider-Gold C: Current and future standards in treatment of myasthenia gravis. Neurotherapeutics 2008; 5: 535-541.
-
(2008)
Neurotherapeutics
, vol.5
, pp. 535-541
-
-
Gold, R.1
Schneider-Gold, C.2
-
2
-
-
44949109211
-
Steroids and immunosuppressant drugs in myasthenia gravis
-
Sathasivam S: Steroids and immunosuppressant drugs in myasthenia gravis. Nat Clin Pract Neuro 2008; 4: 317-327.
-
(2008)
Nat Clin Pract Neuro
, vol.4
, pp. 317-327
-
-
Sathasivam, S.1
-
3
-
-
18144429444
-
Long-term results of tacrolimus in cyclosporine-And prednisone-dependent myasthenia gravis
-
Ponseti JM, Azem J, Fort JM, López-Cano M, Vilallonga R, Buera M, et al: Long-term results of tacrolimus in cyclosporine-And prednisone-dependent myasthenia gravis. Neurology 2005; 64: 1641-1643.
-
(2005)
Neurology
, vol.64
, pp. 1641-1643
-
-
Ponseti, J.M.1
Azem, J.2
Fort, J.M.3
López-Cano, M.4
Vilallonga, R.5
Buera, M.6
-
4
-
-
33748030791
-
Mycophenolate mofetil and tacrolimus: New therapeutic options in neuroimmunological diseases
-
Schneider-Gold C, Hartung HP, Gold R: Mycophenolate mofetil and tacrolimus: new therapeutic options in neuroimmunological diseases. Muscle Nerve 2006; 34: 284-291.
-
(2006)
Muscle Nerve
, vol.34
, pp. 284-291
-
-
Schneider-Gold, C.1
Hartung, H.P.2
Gold, R.3
-
5
-
-
0242331696
-
Japanese fk506 mg study group: Clinical study of fk506 in patients with myasthenia gravis
-
Konishi T, Yoshiyama Y, Takamori M, Yagi K, Mukai E, Saida T; Japanese FK506 MG Study Group: Clinical study of FK506 in patients with myasthenia gravis. Muscle Nerve 2003; 28: 570-574.
-
(2003)
Muscle Nerve
, vol.28
, pp. 570-574
-
-
Konishi, T.1
Yoshiyama, Y.2
Takamori, M.3
Yagi, K.4
Mukai, E.5
Saida, T.6
-
6
-
-
55449109232
-
Treatment of ocular symptoms in myasthenia gravis
-
Bhanushali MJ, Wuu J, Benatar M: Treatment of ocular symptoms in myasthenia gravis. Neurology 2008; 71: 1335-1341.
-
(2008)
Neurology
, vol.71
, pp. 1335-1341
-
-
Bhanushali, M.J.1
Wuu, J.2
Benatar, M.3
-
7
-
-
76649084529
-
Factors associated with response to calcineurin inhibitors in myasthenia gravis
-
Nagane Y, Suzuki S, Suzuki N, Utsugisawa K: Factors associated with response to calcineurin inhibitors in myasthenia gravis. Muscle Nerve 2010; 41: 212-218.
-
(2010)
Muscle Nerve
, vol.41
, pp. 212-218
-
-
Nagane, Y.1
Suzuki, S.2
Suzuki, N.3
Utsugisawa, K.4
-
8
-
-
45249113081
-
Tacrolimus for myasthenia gravis: A clinical study of 212 patients
-
Ponseti JM, Gamez J, Azem J, López-Cano M, Vilallonga R, Armengol M: Tacrolimus for myasthenia gravis: a clinical study of 212 patients. Ann NY Acad Sci 2008; 1132: 254-263.
-
(2008)
Ann NY Acad Sci
, vol.1132
, pp. 254-263
-
-
Ponseti, J.M.1
Gamez, J.2
Azem, J.3
López-Cano, M.4
Vilallonga, R.5
Armengol, M.6
-
9
-
-
34250337206
-
Quality standards subcommittee of the american academy of neurology: Evidence report: The medical treatment of ocular myasthenia (an evidencebased review): Report of the quality standards subcommittee of the american academy of neurology
-
Benatar M, Kaminski HJ; Quality Standards Subcommittee of the American Academy of Neurology: Evidence report: the medical treatment of ocular myasthenia (an evidencebased review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2007; 68: 2144-2149.
-
(2007)
Neurology
, vol.68
, pp. 2144-2149
-
-
Benatar, M.1
Kaminski, H.J.2
|